|
| 36909731 | Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis. | Front Cell Infect Microbiol | 2023 |
| 38016251 | Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry. | ESMO Open | 2023 |
| 37629186 | Tryptophan Modulation in Cancer-Associated Cachexia Mouse Models. | Int J Mol Sci | 2023 |
| 37481109 | Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19. | Int J Infect Dis | 2023 |
| 37738970 | SARS-CoV-2 variants evolve convergent strategies to remodel the host response. | Cell | 2023 |
| 37673443 | Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue disease. | RMD Open | 2023 |
| 37104961 | 3D bioprinted functional skeletal muscle models have potential applications for studies of muscle wasting in cancer cachexia. | Biomater Adv | 2023 |
| 37036865 | Efficacy of T-Cell Receptor-Based Adoptive Cell Therapy in Cutaneous Melanoma: A Meta-Analysis. | Oncologist | 2023 |
| 36649834 | Growing Pulmonary Nodule of Unknown Origin in a 61-Year-Old Woman. | Am J Med | 2023 |
| 35012608 | Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia. | J Hematol Oncol | 2022 |
| 35361487 | Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study. | Gynecol Oncol | 2022 |
| 35356259 | Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies. | Ther Adv Med Oncol | 2022 |
| 36271011 | A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors. | Nat Commun | 2022 |
| 35012962 | Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19. | Life Sci Alliance | 2022 |
| 33946837 | Human Rights in the Least Developed Countries of Asia: An Index for Quantifying Sustainable Development Goal 3 (Good Health and Wellbeing). | Int J Environ Res Public Health | 2021 |
| 33807441 | Tumor-Stromal Interactions in a Co-Culture Model of Human Pancreatic Adenocarcinoma Cells and Fibroblasts and Their Connection with Tumor Spread. | Biomedicines | 2021 |
| 34853302 | Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial. | Nat Commun | 2021 |
| 34075384 | Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization. | medRxiv | 2021 |
| 34242743 | Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy. | Ann Oncol | 2021 |
| 32422543 | Frequency and Clinicopathological Profile Associated with Braf Mutations in Patients with Advanced Melanoma in Spain. | Transl Oncol | 2020 |
| 31870883 | Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies. | J Thorac Oncol | 2020 |
| 32053771 | First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors. | Mol Ther | 2020 |
| 31993963 | SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019). | Clin Transl Oncol | 2020 |
| 31832811 | Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients. | Cancer Chemother Pharmacol | 2020 |
| 31682550 | Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study. | J Clin Oncol | 2020 |
| 31977002 | Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier. | Blood | 2020 |
| 33203665 | Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial. | J Immunother Cancer | 2020 |
| 32919526 | Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. | Lancet Oncol | 2020 |
| 30700322 | Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer. | BMC Res Notes | 2019 |
| 30396819 | Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study. | Pancreatology | 2019 |
| 29349598 | Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer. | Invest New Drugs | 2018 |
| 29977133 | Treatment Patterns and Survival among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France. | Sarcoma | 2018 |
| 30297977 | Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France. | Sarcoma | 2018 |
| 29492229 | Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trials. | Oncotarget | 2018 |
| 29464940 | Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study. | J Cachexia Sarcopenia Muscle | 2018 |
| 29462863 | Effects of Vacation Rental Websites on the Concentration of Tourists-Potential Environmental Impacts. An Application to the Balearic Islands in Spain. | Int J Environ Res Public Health | 2018 |
| 29764853 | Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors. | Clin Cancer Res | 2018 |
| 29177953 | Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study. | Target Oncol | 2018 |
| 29038849 | Malignant bone tumors (other than Ewing's): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS). | Cancer Chemother Pharmacol | 2017 |
| 28231799 | Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin. | Mol Cancer | 2017 |
| 28426120 | A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors. | Ann Oncol | 2017 |
| 28202004 | A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients. | BMC Cancer | 2017 |
| 29384960 | Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study. | Medicine (Baltimore) | 2017 |
| 26786263 | High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer. | Oncologist | 2016 |
| 27269741 | Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial. | Lancet Oncol | 2016 |
| 27317735 | High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer. | Oncologist | 2016 |
| 27185843 | Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study. | J Clin Oncol | 2016 |
| 27568331 | Blood-based biomarkers for monitoring antiangiogenic therapy in non-small cell lung cancer. | Med Oncol | 2016 |
| 26983408 | Safety of vemurafenib in patients with BRAF <sup>V600</sup> mutated metastatic melanoma: the Spanish experience. | Clin Transl Oncol | 2016 |
| 27051831 | A unique case of distant skin metastasis from chondroid chordoma. | JAAD Case Rep | 2016 |